FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 20 filers reported holding FREELINE THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $866,000 | -62.1% | 439,795 | -33.8% | 0.00% | – |
| Q3 2021 | $2,287,000 | -86.0% | 664,836 | -66.8% | 0.00% | -100.0% |
| Q2 2021 | $16,315,000 | -40.2% | 2,001,951 | -9.7% | 0.00% | -40.0% |
| Q1 2021 | $27,271,000 | -36.5% | 2,217,093 | -5.7% | 0.01% | -37.5% |
| Q4 2020 | $42,944,000 | +37.3% | 2,351,773 | +17.4% | 0.01% | +33.3% |
| Q3 2020 | $31,267,000 | – | 2,003,032 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 2,950,000 | $5,841,000 | 5.58% |
| CHI Advisors LLC | 1,876,389 | $3,715,000 | 1.23% |
| TFG Asset Management GP Ltd | 1,522,859 | $3,015,000 | 0.18% |
| Novo Holdings A/S | 1,776,613 | $3,518,000 | 0.17% |
| HARBOR CAPITAL ADVISORS, INC. | 182,521 | $360,000 | 0.13% |
| Eventide Asset Management | 3,485,656 | $6,746,000 | 0.09% |
| Values First Advisors, Inc. | 23,048 | $46,000 | 0.03% |
| Veritable, L.P. | 55,870 | $111,000 | 0.00% |
| SG Americas Securities, LLC | 54,575 | $108,000 | 0.00% |
| Renaissance Technologies | 210,100 | $416,000 | 0.00% |